首页> 美国卫生研究院文献>Iranian Journal of Basic Medical Sciences >Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways
【2h】

Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways

机译:环氧合酶抑制剂与富氘水联合通过激活细胞凋亡和MAPK途径增强A549肺癌细胞系的细胞毒性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective(s):Combination chemotherapy is a rational strategy to increase patient response and tolerability and to decrease adverse effects and drug resistance. Recently, the use of non-steroidal anti-inflammatory drugs (NSAIDs) has been reported to be associated with reduction in occurrence of a variety of cancers including lung cancer. On the other hand, growing evidences suggest that deuterium-enriched water (DEW, D2O) and deuterium-depleted water (DDW) play a role both in treatment and prevention of cancers. In the present study, we examined the effects of DEW and DDW in combination with two NSAIDs, celecoxib and indomethacin, on A549 human non-small lung cancer cell to identify novel treatment options.
机译:目的:联合化疗是增加患者反应和耐受性并减少不良反应和耐药性的合理策略。近来,已经报道使用非甾体抗炎药(NSAID)与减少包括肺癌在内的多种癌症的发生有关。另一方面,越来越多的证据表明,富氘水(DEW,D2O)和贫氘水(DDW)在癌症的治疗和预防中均起着作用。在本研究中,我们检查了DEW和DDW与两种NSAID(塞来昔布和消炎痛)的组合对A549人非小细胞肺癌的影响,以确定新的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号